SCHEMBL27049348

SCHEMBL27049348

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cccc(-c5nc6ccccc6s5)c4)cc3)n2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 11/20 0.61
▸ NPC1 O15118 7/20 0.61
▸ KDM4E B2RXH2 7/20 0.61
▸ MAPT P10636 6/20 0.61
▸ SMN1; SMN2 Q16637 6/20 0.61
▸ NFKB1 P19838 4/20 0.61
▸ NFKB2 Q00653 4/20 0.61
▸ RELA Q04206 4/20 0.61
▸ ALDH1A1 P00352 4/20 0.61
▸ LMNA P02545 3/20 0.61
▸ TP53 P04637 2/20 0.61
▸ HSD17B10 Q99714 2/20 0.61
▸ MEN1 O00255 2/20 0.61
▸ KMT2A Q03164 2/20 0.61
▸ POLB P06746 1/20 0.61
▸ APP P05067 5/20 0.58
▸ MMP9 P14780 1/20 0.58
▸ MMP8 P22894 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.57
▸ GAA P10253 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27049351 0.95 APP (0.60) RAB9ANPC1KDM4EMAPTSMN1; SMN2
SCHEMBL27049375 0.94 RAB9A (0.58) RAB9ANPC1KDM4EMAPTSMN1; SMN2
SCHEMBL19369706 0.94 RAB9A (0.65) RAB9ANPC1KDM4EMAPTSMN1; SMN2
SCHEMBL27258689 0.93 APP (0.54) RAB9ANPC1KDM4EMAPTSMN1; SMN2
SCHEMBL22524395 0.92 RAB9A (0.71) RAB9ANPC1KDM4EMAPTSMN1; SMN2
SCHEMBL19846143 0.90 APP (0.57) RAB9ANPC1KDM4EMAPTSMN1; SMN2
SCHEMBL17701240 0.89 RAB9A (0.67) RAB9ANPC1KDM4EMAPTSMN1; SMN2
SCHEMBL24514780 0.89 APP (0.72) RAB9ANPC1KDM4EMAPTSMN1; SMN2
SCHEMBL13067565 0.89 APP (0.72) RAB9ANPC1KDM4EMAPTSMN1; SMN2
SCHEMBL25864794 0.89 RAB9A (0.56) RAB9ANPC1KDM4EMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240032418-A1 PLURALITY OF HOST MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2024-01-25 — — US disclosed
US-20240032418-A1 PLURALITY OF HOST MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2024-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240032418-A1 PLURALITY OF HOST MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ELAVL1, L3MBTL4, PIEZO1 RAB9A 1275/4885NPC1 3481/4885KDM4E 2192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback